drugset / Trial / NCT07680686
Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
RandomizedCrossoverOpen-labelBasic science
Summary
This study will assess how different oral formulations of ubrogepant move through the body in healthy adult participants under fasting and fed conditions.
Timeline
- Start
- 2026-06-30
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ubrogepant | Small molecule | — | Oral |
Indications
No indication recorded.